A Study of Prescribing Habits of Low Molecular Weight Heparin in Cardiovascular Disease in Tertiary Care Hospital

Simple item page
dc.contributor.authorMadhaw Dwivedi
dc.contributor.authorS. M. Biradar
dc.contributor.authorAjay Pandey
dc.contributor.authorAnand P. Ambali
dc.contributor.authorRishu Sharma
dc.date.accessioned2025-12-17T09:29:32Z
dc.date.available2025-12-17T09:29:32Z
dc.date.issued2017-05-05
dc.description.abstractBackground and Objective: Cardiovascular Diseases (CVDs) are the leading non-communicable diseases and also leading cause of morbidity and mortality worldwide. Low Molecular Weight Heparin (LMWHs) is frequently prescribed medication in CVDs. Prescribing pattern of LMWHs in CVDs is necessary to recommends modifications to achieve rational and cost-effective medical care. Methodology: An inpatients hospital based observational prospective study for a period of six months was carried out. Data was collected from patient medication sheet and analyzed by suitable methods and standard references. Results and Discussion: In our study, a total of 120 patients were enrolled out of 120 patients 84 were male and 36 were female. Antiplatelet drug is maximum prescribing drug in 98 (81.34%) patients out of 120, then after hypolipidaemic drugs in 94 (78.02%), Anticoagulant in 92 (76.36%), Antibiotics in 90 (74.70%), Antianginal in 69 (57.27), Antihypertensive in 64 (53.12%), Diuretics in 59 (48.97%). LMWHs are prescribed in 78 (65%) in which Enoxaparin is prescribed in 67(55%) and Dalteparin in 11(10%) patients out of 120 patients. Total 259 Drug-Drug Interactions (DDI) were found in which 67 were Major, 140 were Moderate, and 52 were Minor. Conclusion: The study show LMWHs are highly prescribed category of anticoagulant. Enoxaparin is prescribed morethan Dalteparin. Antiplatelet drugs are prescribed to every patient who is prescribed with LMWHs to prevent embolic event. Chance of DDI is increases with these combinations. LMWHs and Fibrinolytic drugs are very costly and impart maximum economic burden to middle class family.
dc.identifier.issn2321-2217
dc.identifier.issn2321-2225
dc.identifier.otherhttps://doi.org/10.15415/jptrm.2017.51005
dc.identifier.urihttps://demodspace.chitkara.edu.in/handle/123456789/205
dc.language.isoen
dc.publisherChitkara University Publications
dc.subjectCardiovascular diseases
dc.subjectDrug- Drug Interactions
dc.subjectHeparin
dc.subjectLow Molecular Weight Heparin
dc.titleA Study of Prescribing Habits of Low Molecular Weight Heparin in Cardiovascular Disease in Tertiary Care Hospital
dc.typeArticle

Files

Collections

JPTRM Vol. 5 No. 1 (May 2017)